CVE:SQD - SQI Diagnostics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
C$0.08 0.00 (0.00 %)
(As of 01/18/2019 01:55 PM ET)
Previous CloseC$0.08
Today's RangeC$0.08 - C$0.08
52-Week RangeC$0.05 - C$0.30
VolumeN/A
Average Volume58,689 shs
Market CapitalizationN/A
P/E Ratio-1.40
Dividend YieldN/A
BetaN/A
SQI Diagnostics Inc., a life sciences company, develops and commercializes proprietary technologies and products for advanced multiplexing diagnostics in Canada. The company offers sqidworks diagnostic platform, a fully-automated microarray processing and analytical system; sqidlite benchtop diagnostic platform, a fully automated bench top microarray processing and analytical system; and sqid-X, a semi-automated bench-top platform. Its products are used in immunogenicity and bioanalysis, IVD and clinical, biomarkers, and assay development applications. SQI Diagnostics Inc. has a co-develop and licensing agreement with McMaster University Department of Engineering to develop chip technology for use in multi-array disease testing. The company was founded in 1999 and is headquartered in Toronto, Canada.

Receive SQD News and Ratings via Email

Sign-up to receive the latest news and ratings for SQD and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Diagnostics & Research
Sub-IndustryN/A
SectorMedical
CUSIPN/A
Phone+1-416-6749500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesC$1.34 million
Cash FlowC$0.02 per share
Book ValueC$0.01 per share

Profitability

Miscellaneous

Employees42
OptionableNot Optionable

SQI Diagnostics (CVE:SQD) Frequently Asked Questions

What is SQI Diagnostics' stock symbol?

SQI Diagnostics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "SQD."

How were SQI Diagnostics' earnings last quarter?

SQI Diagnostics Inc. (CVE:SQD) announced its quarterly earnings data on Tuesday, December, 11th. The company reported ($0.01) EPS for the quarter. The business earned $0.56 million during the quarter. View SQI Diagnostics' Earnings History.

When is SQI Diagnostics' next earnings date?

SQI Diagnostics is scheduled to release their next quarterly earnings announcement on Monday, February 4th 2019. View Earnings Estimates for SQI Diagnostics.

Has SQI Diagnostics been receiving favorable news coverage?

Media stories about SQD stock have been trending somewhat positive this week, InfoTrie Sentiment reports. InfoTrie identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SQI Diagnostics earned a media sentiment score of 1.6 on InfoTrie's scale. They also assigned news stories about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future.

Who are some of SQI Diagnostics' key competitors?

Who are SQI Diagnostics' key executives?

SQI Diagnostics' management team includes the folowing people:
  • Mr. Andrew Morris, CEO, Pres & Director (Age 53)
  • Ms. Patricia Lie CPA, CA, VP of Fin. & Admin.
  • Dr. Peter Lea Ph.D., Founder (Age 74)
  • Dr. Eric Brouwer, Chief Scientific Officer
  • Mr. Russell Peloquin, VP of Global Commercial Operations

How do I buy shares of SQI Diagnostics?

Shares of SQD and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is SQI Diagnostics' stock price today?

One share of SQD stock can currently be purchased for approximately C$0.08.

What is SQI Diagnostics' official website?

The official website for SQI Diagnostics is http://sqidiagnostics.com/.

How can I contact SQI Diagnostics?

SQI Diagnostics' mailing address is 36 Meteor Dr, ETOBICOKE, ON M9W 1A4, Canada. The company can be reached via phone at +1-416-6749500.


MarketBeat Community Rating for SQI Diagnostics (CVE SQD)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  46 (Vote Outperform)
Underperform Votes:  44 (Vote Underperform)
Total Votes:  90
MarketBeat's community ratings are surveys of what our community members think about SQI Diagnostics and other stocks. Vote "Outperform" if you believe SQD will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SQD will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/18/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel